XML 66 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9
Earnings Per Share (Tables)
 9 Months Ended
Mar. 31, 2015
Notes to Financial Statements [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Net earnings attributable to Procter & Gamble and common shares used to calculate basic and diluted net earnings per share were as follows:
 
Three Months Ended March 31, 2015
 
Three Months Ended March 31, 2014
CONSOLIDATED AMOUNTS
Continuing Operations
Discontinued Operations
Total
 
Continuing Operations
Discontinued Operations
Total
Net earnings/(loss)
$
2,475

$
(287
)
$
2,188

 
$
2,531

$
105

$
2,636

Net earnings attributable to noncontrolling interests
(35
)
—

(35
)
 
(21
)
(6
)
(27
)
Net earnings attributable to P&G (Diluted)
2,440

(287
)
2,153

 
2,510

99

2,609

Preferred dividends, net of tax benefit
(59
)
—

(59
)
 
(57
)
—

(57
)
Net earnings/(loss) attributable to P&G available to Common Shareholders (Basic)
$
2,381

$
(287
)
$
2,094

 
$
2,453

$
99

$
2,552

 
 
 
 
 
 
 
 
SHARES IN MILLIONS
 
 
 
 
 
 
 
Basic weighted average common shares outstanding
2,711.7

2,711.7

2,711.7

 
2,713.1

2,713.1

2,713.1

Effect of dilutive securities
 
 
 
 
 
 
 
Conversion of preferred shares (1)
108.1

108.1

108.1

 
111.9

111.9

111.9

Exercise of stock options and other unvested equity awards (2)
62.7

62.7

62.7

 
69.1

69.1

69.1

Diluted weighted average common shares outstanding
2,882.5

2,882.5

2,882.5

 
2,894.1

2,894.1

2,894.1

 
 
 
 
 
 
 
 
PER SHARE AMOUNTS (3)
 
 
 
 
 
 
 
Basic net earnings/(loss) per common share
$
0.88

$
(0.11
)
$
0.77

 
$
0.90

$
0.04

$
0.94

Diluted net earnings/(loss) per common share
$
0.85

$
(0.10
)
$
0.75

 
$
0.87

$
0.03

$
0.90

 
 
 
 
 
 
 
 
 
Nine Months Ended March 31, 2015
 
Nine Months Ended March 31, 2014
CONSOLIDATED AMOUNTS
Continuing Operations
Discontinued Operations
Total
 
Continuing Operations
Discontinued Operations
Total
Net earnings/(loss)
$
8,290

$
(1,684
)
$
6,606

 
$
8,762

$
403

$
9,165

Net earnings attributable to noncontrolling interests
(85
)
(6
)
(91
)
 
(85
)
(16
)
(101
)
Net earnings attributable to P&G (Diluted)
8,205

(1,690
)
6,515

 
8,677

387

9,064

Preferred dividends, net of tax benefit
(189
)
—

(189
)
 
(182
)
—

(182
)
Net earnings/(loss) attributable to P&G available to Common Shareholders (Basic)
$
8,016

$
(1,690
)
$
6,326

 
$
8,495

$
387

$
8,882

 
 
 
 
 
 
 
 
SHARES IN MILLIONS
 
 
 
 
 
 
 
Basic weighted average common shares outstanding
2,709.4

2,709.4

2,709.4

 
2,722.5

2,722.5

2,722.5

Effect of dilutive securities
 
 
 
 
 
 
 
Conversion of preferred shares (1)
109.1

109.1

109.1

 
112.7

112.7

112.7

Exercise of stock options and other unvested equity awards (2)
66.8

66.8

66.8

 
73.7

73.7

73.7

Diluted weighted average common shares outstanding
2,885.3

2,885.3

2,885.3

 
2,908.9

2,908.9

2,908.9

 
 
 
 
 
 
 
 
PER SHARE AMOUNTS (3)
 
 
 
 
 
 
 
Basic net earnings/(loss) per common share
$
2.96

$
(0.63
)
$
2.33

 
$
3.12

$
0.14

$
3.26

Diluted net earnings/(loss) per common share
$
2.84

$
(0.58
)
$
2.26

 
$
2.99

$
0.13

$
3.12

(1) 
Despite being included currently in diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035.
(2) 
For the three months ended March 31, 2015 and March 31, 2014 approximately 10 million and 15 million of the Company's outstanding stock options and for the nine months ended March 31, 2015 and March 31, 2014 approximately 4 million of the Company's outstanding stock options were not included in the diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares).
(3) 
Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble.